ライフサイエンスコーパス: elevated intraocular pressure

1 ly impede aqueous humor outflow resulting in elevated intraocular pressure.

2 shown to be upregulated in TM in response to elevated intraocular pressure.

3 sues under circumstances of physiological or elevated intraocular pressure.

4 ptic nerve, which is usually associated with elevated intraocular pressure.

5 optic nerve head, frequently associated with elevated intraocular pressure.

6 a agonists that are used in the treatment of elevated intraocular pressure.

7 e optic nerve and is usually associated with elevated intraocular pressure.

8 eld defects that is often associated with an elevated intraocular pressure.

9 sented with bilateral eye pain, redness, and elevated intraocular pressure.

10 unilateral cataract, ocular inflammation and elevated intraocular pressure.

11 ked reduction in retinal layer thickness and elevated intraocular pressure.

12 ng progressive vision loss, ocular pain, and elevated intraocular pressure.

13 ination revealed bilateral closed angles and elevated intraocular pressure.

14 The primary risk factor for glaucoma is elevated intraocular pressure.

15 tive cells are sensitive to damage caused by elevated intraocular pressure.

16 mice form a severely hypomorphic canal with elevated intraocular pressure.

17 LK), duration of steroid administration, and elevated intraocular pressure.

18 iridocorneal angle exhibited a significantly elevated intraocular pressure.

19 in vivo following experimental induction of elevated intraocular pressure.

20 be used to treat suspicion of even slightly elevated intraocular pressure.

21 nlarged eye phenotype, presumably because of elevated intraocular pressure.

22 p explain the loss of RGCs in the absence of elevated intraocular pressure.

23 ying racial differences in susceptibility to elevated intraocular pressure.

24 001), and carboxyfluorescein (P = 0.0064) at elevated intraocular pressures.

25 VH (498 eyes, 53%), cataract (465, 50%), and elevated intraocular pressure (149, 16%) being the most

26 es, 3 + anterior chamber and vitreous cells, elevated intraocular pressure (26 mmHg), a blurred optic

27 ions were vitreous hemorrhage (8.2%, 0-41%), elevated intraocular pressure (7.3%, 0-25%), and catarac

28 ncluded iris abnormalities (11 eyes, 45.8%), elevated intraocular pressure (8 eyes, 33.3%), corneal e

29 med Glaucoma Valve Implantation to alleviate elevated intraocular pressure after ocular trauma to the

30 Elevated intraocular pressure and cataract progression a

31 Elevated intraocular pressure and glaucoma are the most

32 terior segment of the eye frequently develop elevated intraocular pressure and glaucoma.

33 Because elevated intraocular pressure and ischemia are two promi

34 Control individuals had no elevated intraocular pressure and no signs of glaucoma.

35 head is specific to tissue remodeling due to elevated intraocular pressure and not secondary to loss

36 iris pigment release and often progresses to elevated intraocular pressure and pigmentary glaucoma (P

37 hat calpain is activated under conditions of elevated intraocular pressure and provide further detail

38 re in mice; TRPV4 knockout animals exhibited elevated intraocular pressure and shortened cilia.

39 e myocilin (MYOC, GLC1A) are associated with elevated intraocular pressure and the development of aut

40 vide insight into a potential contributor to elevated intraocular pressure and thus to probability of

41 Five eyes demonstrated elevated intraocular pressure, and 4 eyes demonstrated a

42 After crush injury to the optic nerve, elevated intraocular pressure, and glutamate toxicity, t

43 Age, elevated intraocular pressure, and positive family histo

44 lular ATP levels in the retina increase with elevated intraocular pressure, and stimulation of P2X(7)

45 .53), age (AOR: 3.21, 95% CI: 1.92-5.99) and elevated intraocular pressure (AOR: 3.09, 95% CI: 1.45-6

46 Elevated intraocular pressure as the result of abnormal

47 mor from the eye, and the tissue involved in elevated intraocular pressure associated with glaucoma.

48 eterioration related to antiepileptic drugs, elevated intraocular pressure associated with inhaled co

49 s had a suspect optic disc appearance and/or elevated intraocular pressure, but normal visual fields.

50 Glaucoma traditionally is associated with elevated intraocular pressure, but often occurs or may p

51 No adverse events (elevated intraocular pressure, cataract) were observed i

52 creased potential ocular side effects (e.g., elevated intraocular pressure, cataracts).

53 If pores are physiological structures, the elevated intraocular pressure characteristic of glaucoma

54 eased flow resistance is responsible for the elevated intraocular pressure characteristic of glaucoma

55 lity, processes that could contribute to the elevated intraocular pressure characteristic of PCG.

56 nificantly lower rate of graft rejection and elevated intraocular pressure compared to DSAEK and PK f

57 c/Tigr mRNA in the retina after induction of elevated intraocular pressure compared with that in the

58 amethasone treatment in these strains led to elevated intraocular pressure compared with the GC nonre

59 This sustained elevated intraocular pressure could lead to higher rates

60 same as those seen in single oil tamponade (elevated intraocular pressure, cystoid macular oedema (C

61 ch decrease the common causal risk factor of elevated intraocular pressure, delay, but cannot prevent

62 on-cultured human eyes, in which DEX-induced elevated intraocular pressure developed.

63 Elevated intraocular pressure due to a reduction in norm

64 A major risk factor for glaucoma is elevated intraocular pressure due to increased resistanc

65 leral permeability was similarly affected by elevated intraocular pressure for water (P = 0.0039), de

66 atients with COVID-19 can be associated with elevated intraocular pressure from periorbital edema, di

67 6%, scleral necrosis in 3%, cataract in 53%, elevated intraocular pressure (from tumor or radiotherap

68 c keratitis, band keratopathy, corneal melt, elevated intraocular pressure, glaucoma, and cataract (a

69 ased incidence of central vein occlusion and elevated intraocular pressure going along with chamber a

70 synechiae (aHR 3.71, 95% CI 2.83-4.87), and elevated intraocular pressure >=30 vs 6-20 mm Hg (aHR 2.

71 postoperative occurrence of GRAE, defined as elevated intraocular pressure (>21 mmHg), initiation of

72 ve damage, associated visual field loss, and elevated intraocular pressure (>22 mm Hg in both eyes).

73 d to enucleation due to phthisis bulbi), and elevated intraocular pressure in 3 patients (2 eyes in t

74 ere no serious adverse events; 1 subject had elevated intraocular pressure in both eyes.

75 ency requiring prompt treatment to lower the elevated intraocular pressure in humans and dogs.

76 We elevated intraocular pressure in one eye and determined

77 the TM is thought to be the primary cause of elevated intraocular pressure in primary open-angle glau

78 anism by which laser trabeculoplasty reduces elevated intraocular pressure in primary open-angle glau

79 Elevated intraocular pressure in the RhoAV14-expressing

80 Causes of elevated intraocular pressure included angle infiltratio

81 In DBA/2 retina, elevated intraocular pressure increased microglial IL-6

82 P<0.01), proptosis (64.3% vs 21.2%, P<0.01), elevated intraocular pressure (IOP) (35.7% vs 12.5%, P<0

83 of irreversible vision loss worldwide, with elevated intraocular pressure (IOP) a major risk factor.

84 tomy with mitomycin C (MMC) for uncontrolled elevated intraocular pressure (IOP) after corneal graft

85 Elevated intraocular pressure (IOP) and decreased ocular

86 Elevated intraocular pressure (IOP) and glaucoma are som

87 Primary open-angle glaucoma (POAG) leads to elevated intraocular pressure (IOP) and gradual optic ne

88 (TM) that attenuates aqueous humor outflow, elevated intraocular pressure (IOP) and retinal ganglion

89 To determine the incidence of elevated intraocular pressure (IOP) and secondary glauco

90 use of visual impairment and blindness, with elevated intraocular pressure (IOP) as a major causative

91 n optic neuropathy, commonly associated with elevated intraocular pressure (IOP) characterized by opt

92 blindness, remains poorly defined, although elevated intraocular pressure (IOP) contributes to the d

93 tor of primary open-angle glaucoma (POAG) is elevated intraocular pressure (IOP) due to increased aqu

94 Elevated intraocular pressure (IOP) due to insufficient

95 put neurons of the retina and are injured by elevated intraocular pressure (IOP) in diseases such as

96 proposed as a next-generation treatment for elevated intraocular pressure (IOP) in glaucoma, the mos

97 ared with each active component, in reducing elevated intraocular pressure (IOP) in patients with ope

98 Because elevated intraocular pressure (IOP) is a major risk fact

99 Elevated intraocular pressure (IOP) is a major risk fact

100 Elevated intraocular pressure (IOP) is a major risk fact

101 Elevated intraocular pressure (IOP) is a major risk fact

102 Elevated intraocular pressure (IOP) is a major risk fact

103 Elevated intraocular pressure (IOP) is a major risk fact

104 Elevated intraocular pressure (IOP) is a major risk fact

105 Elevated intraocular pressure (IOP) is a risk factor for

106 Elevated intraocular pressure (IOP) is a well-known adve

107 Elevated intraocular pressure (IOP) is an important risk

108 Elevated intraocular pressure (IOP) is an important risk

109 An elevated intraocular pressure (IOP) is considered to be

110 Elevated intraocular pressure (IOP) is one of the main r

111 NH) is the likely site of initial injury and elevated intraocular pressure (IOP) is the best-known ri

112 Elevated intraocular pressure (IOP) is the major risk fa

113 Chronically elevated intraocular pressure (IOP) is the major risk fa

114 principal site of initial axonal injury, and elevated intraocular pressure (IOP) is the predominant r

115 Elevated intraocular pressure (IOP) is the principal ris

116 coma is a neurodegenerative disease in which elevated intraocular pressure (IOP) leads to progressive

117 Elevated intraocular pressure (IOP) narrows Schlemm's ca

118 To evaluate the effect of acutely elevated intraocular pressure (IOP) on retinal thickness

119 ayer (RNFL) thickness change associated with elevated intraocular pressure (IOP) over a period of tim

120 Optic nerve crush, excitotoxicity, and elevated intraocular pressure (IOP) rat models were used

121 Early screening and treatment of elevated intraocular pressure (IOP) reduces both the dev

122 Improving adherence to manage elevated intraocular pressure (IOP) remains an unmet nee

123 nited States and is commonly associated with elevated intraocular pressure (IOP) resulting from dimin

124 Transgenic Col1a1(r/r) mice develop elevated intraocular pressure (IOP) with an open angle a

125 nsgenic (Col1a1(r/r)) mice gradually develop elevated intraocular pressure (IOP) with open angles.

126 Five patients (28%) had elevated intraocular pressure (IOP) within 1 day of trea

127 at least one of the following criteria: (1) elevated intraocular pressure (IOP), (2) suspicious opti

128 e vision loss worldwide, is characterized by elevated intraocular pressure (IOP), a well-established

129 nerative disease, whose risk factors include elevated intraocular pressure (IOP), age, and genetics,

130 No other complications, such as hypotony, elevated intraocular pressure (IOP), corneal edema, irit

131 laucoma, a leading cause of blindness due to elevated intraocular pressure (IOP), is managed with med

132 Thbs1R1034C-mutant mice had elevated intraocular pressure (IOP), reduced ocular flui

133 Elevated intraocular pressure (IOP), sensed as mechanica

134 Elevated intraocular pressure (IOP), the major causal ri

135 nset presentation of corneal decompensation, elevated intraocular pressure (IOP), uveitis and hyphema

136 aly (ARA), variably associate with harmfully elevated intraocular pressure (IOP), which causes glauco

137 Elevated intraocular pressure (IOP), which causes optic

138 is disease are a positive family history and elevated intraocular pressure (IOP), which is also highl

139 equently leads to ocular hypertension, i.e., elevated intraocular pressure (IOP), which, in turn, can

140 rejection, graft failure, and postoperative elevated intraocular pressure (IOP)-in patients with FED

141 die by apoptosis, generally attributed to an elevated intraocular pressure (IOP).

142 nal ischemia-reperfusion injury by transient elevated intraocular pressure (IOP).

143 nd optic nerve damage, often associated with elevated intraocular pressure (IOP).

144 om retinal ganglion cell (RGC) loss, despite elevated intraocular pressure (IOP).

145 e transfer tool for the control of nocturnal elevated intraocular pressure (IOP).

146 ments as early as 7 d following induction of elevated intraocular pressure (IOP).

147 alphaGCs) in dark-adapted mouse retinas with elevated intraocular pressure (IOP).

148 rdation, birefringence, and reflectance with elevated intraocular pressure (IOP).

149 s examined after retinal ischemia induced by elevated intraocular pressure (IOP).

150 J mouse model of glaucoma with spontaneously elevated intraocular pressure (IOP).

151 he best-known risk factor for glaucoma is an elevated intraocular pressure (IOP); however, factors le

152 umor outflow structures of the eye result in elevated intraocular pressure (IOP); however, the genes

153 analyzed in GA-immunized versus nonimmunized elevated-intraocular pressure (IOP) rat models of glauco

154 that they display glaucoma phenotypes (i.e., elevated intraocular pressure [IOP], retinal ganglion ce

155 meshwork dysfunction, resulting in markedly elevated intraocular pressures (IOPs) at young ages.

156 Elevated intraocular pressure is a highly heritable risk

157 Elevated intraocular pressure is a major risk factor for

158 Since elevated intraocular pressure is a significant risk fact

159 Elevated intraocular pressure is associated with glaucom

160 The mechanism of elevated intraocular pressure is increased aqueous outfl

161 Although not always elevated, intraocular pressure is the only modifiable ri

162 Complications included elevated intraocular pressure leading to glaucoma; catar

163 Taken together, elevated intraocular pressure mediated increase in ET(B)

164 mply that treatment of risk factors, such as elevated intraocular pressure, must not be continuously

165 pectively, P = .17), indicating that neither elevated intraocular pressure nor low blood pressure cou

166 Corticosteroid-associated AEs of elevated intraocular pressure occurred in 11.5% and 15.6

167 We hypothesize that elevated intraocular pressure occurring during proptosis

168 ut 40% of the general population may develop elevated intraocular pressure on prolonged glucocorticoi

169 e clinically observed by examination such as elevated intraocular pressure, optic nerve head appearan

170 o glaucoma models where RGCs degenerate from elevated intraocular pressure or genetic deficiency.

171 te the unfolded protein response and lead to elevated intraocular pressure or glaucoma in aged mice o

172 lowering medications in eyes with persistent elevated intraocular pressure or glaucoma.

173 Multiple entities not associated with elevated intraocular pressure or glaucomatous optic-nerv

174 inflammation (OR 1.73, P < .0001), prolonged elevated intraocular pressure (OR 2.96, P = .0003), and

175 not associated with decreased visual acuity, elevated intraocular pressure, or documentation of senol

176 ma (P = .96), retinal detachment (P = .096), elevated intraocular pressure (P = .88), or suprachoroid

177 Elevated intraocular pressure (P<0.001) was associated s

178 - standard deviation [SD], 30.0+/-19.0%) and elevated intraocular pressure (range, 2.4%-64.0%; mean +

179 We have demonstrated that the elevated intraocular pressure seen in the uveitic glauco

180 na from adult mice subjected to two weeks of elevated intraocular pressure showing degeneration.

181 t common form of glaucoma-include older age, elevated intraocular pressure, sub-Saharan African ethni

182 ma with significant growth, vision loss, and elevated intraocular pressure that was diagnosed clinica

183 sed as unrelated to treatment, and events of elevated intraocular pressure trended higher in the acti

184 implantation include hypotony, postoperative elevated intraocular pressure, tube erosion, diplopia, m

185 Highly elevated intraocular pressures usually present the most

186 Elevated intraocular pressure was induced unilaterally b

187 Elevated intraocular pressure was not included in the ca

188 Exposure to elevated intraocular pressure was similar in all groups.

189 ad occurs in response to loss of axons or to elevated intraocular pressure we compared the patterns o

190 glaucomatous mutations in mouse eyes causes elevated intraocular pressure, which is a major phenotyp

191 The major risk factor for glaucoma is elevated intraocular pressure, which is regulated by the